1Hughes WT,Armstrong D,Bodey GP,et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J]. Clin Infect Dis,2002,15:34(6) :730 -751. 被引量：1
2Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[ J ]. N Engl J Med,2002,347(6) :408 -415. 被引量：1
3Castagnola E, Machetti M, Cappelli B, et al. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant [ J]. Clin Microbiol Infect,2004,10(3) :255 -257. 被引量：1
4Landman D, Mobarakai NK, Quale JM. Novel antibiotic regimens against Enterococcus faecinm resistant to ampicillin, vancomycin, and gentamicin. Antimicrob [ J ]. Agents Chemother, 1993,37 (9) : 1904 - 1908. 被引量：1
2Huang XJ,Shen ZX,Wang C,et al.Clinical guidelines for management of cancer patients with neutropenia and unexplained fever.Int J Antimicrob Agents,2005,26S:S128-132. 被引量：1
3Karthaus M,Cornely OA.Recent developments in the management of invasive fungal infections in patients with hematological malignancies.Ann Hematol,2005,84:207-216. 被引量：1
4Odabasi Z,Mattiuzzi G,Estey E,et al.Beta-D-glucan as a diagnostic adjunct for invasive fungal infections:validation,cutoff development,and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.Clin Infect Dis,2004,39:199-205. 被引量：1
5Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med,2003,348:1546-1554. 被引量：1
6Bhatti Z,Shaukat A,Almyroudis NG,et al.Review of epidemiology,diagnosis,and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.Mycopathogia,2006,162:1-15. 被引量：1
7Kieren AM,Rachel AC,Michael B,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100:4358-4366. 被引量：1
8Rubin RH,Marty FM.Principles of antimicrobial therapy in the transplant patient.Transpl Infect Dis,2004,6:97-100. 被引量：1
